Effectiveness and Safety of Lysozyme Chloride-Based Cream on Healing of Grade-Two Pressure Ulcers: A Pilot Study

Keywords: Lysozyme, Pressure ulcer, Therapy, Povidone-iodine, Light, polarised

Abstract


Background/Aim: Pressure ulcers develop due to prolonged periods of increased pressure on certain parts of the skin and underlying tissue. This study aimed to evaluate the efficacy and safety estimates of lysozyme-based cream in the treatment of pressure ulcers of grade two according to Yarkony-Kirk scale

Methods: Adult patients with neurological diseases and severe functional deficits with grade-two pressure ulcers according to Yarkony-Kirk scale were included. All patients were treated with polarised light. Additionally, the patients were treated twice daily with a cream containing 20 mg/g of lysozyme chloride (lysozyme group) or with povidone-iodine dressings (control group). Visual checks of the ulcer were performed at the baseline and daily until the end of follow-up. Safety was evaluated by the presence of adverse reactions to treatment. Patients were followed for two months or less in case of withdrawal from the study, ulcer healing, or worsening. The Yarkony-Kirk scale grade was determined at the end of follow-up for each patient and one of the four categories was recorded: healed, improved, no changes or worsened.

Results: A total of 48 subjects were included, 28 (58 %) in the lysozyme and 20 (42 %) in the control group. Age, sex, pressure ulcer position and duration of follow-up were similar between groups. The percentage of healed pressure ulcers was significantly higher in the lysozyme (71 %) compared to the control (35 %) group (p = 0.005). No adverse reactions to treatments were recorded. 

Conclusion: The lysozyme-based cream was found to be effective and safe in the treatment of grade-two pressure ulcers. Additional randomised, blinded, larger studies are needed to confirm these findings.

References

Kumar S, Theis T, Tschang M, Nagaraj V, Berthiaume F. Reactive oxygen species and pressure ulcer formation after traumatic injury to spinal cord and brain. Antioxidants (Basel). 2021 Jun 24;10(7):1013. doi: 10.3390/antiox10071013.

De Francesco F, Ogawa R. From time to timer in wound healing through the regeneration. Adv Exp Med Biol 2024; doi: 10.1007/5584_2024_815.

European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel, Pan Pacific Pressure Injury Alliance; Haesler E, ed. Prevention and treatment of pressure ulcers/injuries: clinical practice guideline. The International Guideline. Schaumburg, IL: EPUAP/NPIAP/PPPIA; 2019.

Alito A, Portaro S, Leonardi G, Ventimiglia C, Bonanno F, Fenga D, et al.. Pressure ulcers-a longstanding problem: a 7-year neurorehabilitation unit experience of management, care, and clinical outcomes. Diagnostics (Basel). 2023 Oct 14;13(20):3213. doi: 10.3390/diagnostics13203213.

Yarkony GM, Kirk PM, Carlson C, Roth EJ, Lovell L, Heinemann A, et al. Classification of pressure ulcers. Arch Dermatol. 1990 Sep;126(9):1218-9. PMID: 2101585.

Krishnan S, Hong I, Couture G, Tzen YT, Reistetter T. Pressure injury on poststroke admission assessment to skilled nursing facilities: risk factors, management, and impact on rehabilitation. J Am Med Dir Assoc. 2022 Oct;23(10):1718.e13-1718.e20. doi: 10.1016/j.jamda.2022.06.025.

Berlowitz DR, Brandeis GH, Anderson J, Du W, Brand H. Effect of pressure ulcers on the survival of long-term care residents. J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M106-10. doi: 10.1093/gerona/52a.2.m106.

Reddy M, Keast D, Fowler E, Sibbald RG. Pain in pressure ulcers. Ostomy Wound Manage. 2003 Apr;49(4 Suppl):30-5. PMID: 12856291.

Fernando-Canavan L, Gust A, Hsueh A, Tran-Duy A, Kirk M, Brooks P, et al. Measuring the economic impact of hospital-acquired complications on an acute health service. Aust Health Rev. 2021 Mar;45(2):135-42. doi: 10.1071/AH20126.

Sørensen JL, Jørgensen B, Gottrup F. Surgical treatment of pressure ulcers. Am J Surg 2004;188(1A Suppl):42–51; doi: 10.1016/S0002-9610(03)00290-3.

Afzali Borojeny L, Albatineh AN, Hasanpour Dehkordi A, Ghanei Gheshlagh R. The incidence of pressure ulcers and its associations in different wards of the hospital: a systematic review and meta-analysis. Int J Prev Med. 2020 Oct 5;11:171. doi: 10.4103/ijpvm.IJPVM_182_19.

Patton D, Moore ZE, Boland F, Chaboyer WP, Latimer SL, Walker RM, et al. Dressings and topical agents for preventing pressure ulcers. Cochrane Database Syst Rev. 2024 Dec 3;12(12):CD009362. doi: 10.1002/14651858.CD009362.pub4.

Ragland SA, Criss AK. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme. PLoS Pathog. 2017;13(9):e1006512; doi: 10.1371/journal.ppat.1006512.

Zhang XL, Lei Y, Xiao YB, Cao XY, Tian XY, Zhu YX, et al. Hen egg lysozyme alleviates static mechanical pain via NRF1-Parkin-TACAN signaling axis in sensory neurons. Neuroscience. 2022 Oct 15;502:52-67. doi: 10.1016/j.neuroscience.2022.08.010.

Bianchi C. Is Fleming’s lysozyme an analgesic agent? An experimental reappraisal of clinical data. Eur J Pharmacol 1981;71(2–3):211–21; doi: 10.1016/0014-2999(81)90024-8.

Bianchi C. Is Fleming’s lysozyme an analgesic agent? Experiments on mice. Clin Exp Pharmacol Physiol 1983;10(1):45–52; doi: 10.1111/j.1440-1681.1983.tb00170.x.

Anonymous. R: The R Project for Statistical Computing. n.d. [Internet] [Cited: 16-Oct-2024]. Available from: https://www.r-project.org/.

Saeg F, Schoenbrunner AR, Janis JE. Evidence-based wound irrigation: separating fact from fiction. Plast Reconstr Surg 2021;148(4):601e–614e; doi: 10.1097/PRS.0000000000008331.

Wang L, Qin W, Zhou Y, Chen B, Zhao X, Zhao H, et al. Transforming growth factor β plays an important role in enhancing wound healing by topical application of Povidone-iodine. Sci Rep. 2017 Apr 20;7(1):991. doi: 10.1038/s41598-017-01116-5.

Lee BY, Trainor FS, Thoden WR. Topical application of povidone-iodine in the management of decubitus and stasis ulcers. J Am Geriatr Soc 1979;27(7):302–6; doi: 10.1111/j.1532-5415.1979.tb06044.x.

Norman G, Dumville JC, Moore ZE, Tanner J, Christie J, Goto S. Antibiotics and antiseptics for pressure ulcers. Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD011586. doi: 10.1002/14651858.CD011586.pub2.

Michel D, Zäch GA. Antiseptic efficacy of disinfecting solutions in suspension test in vitro against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in pressure sore wounds after spinal cord injury. Dermatology. 1997;195 Suppl 2:36–41; doi: 10.1159/000246028.

Nahlieli O, Baruchin AM, Levi D, Shapira Y, Yoffe B. Povidone-iodine related burns. Burns. 2001 Mar;27(2):185-8. doi: 10.1016/s0305-4179(00)00081-4.

Aronoff GR, Friedman SJ, Doedens DJ, Lavelle KJ. Increased serum iodide concentration from iodine absorption through wounds treated topically with povidone-iodine. Am J Med Sci. 1980 May-Jun;279(3):173-6. doi: 10.1097/00000441-198005000-00007.

Callewaert L, Michiels CW. Lysozymes in the animal kingdom. J Biosci 2010;35(1):127–60; doi: 10.1007/s12038-010-0015-5.

Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 2019 Apr;27(4):323-338. doi: 10.1016/j.tim.2018.12.010.

Khorshidian N, Khanniri E, Koushki MR, Sohrabvandi S, Yousefi M. An overview of antimicrobial activity of lysozyme and its functionality in Cheese. Front Nutr. 2022 Mar 9;9:833618. doi: 10.3389/fnut.2022.833618.

Hasmann A, Wehrschuetz-Sigl E, Kanzler G, Gewessler U, Hulla E, Schneider KP, et al. Novel peptidoglycan-based diagnostic devices for detection of wound infection. Diagn Microbiol Infect Dis. 2011 Sep;71(1):12-23. doi: 10.1016/j.diagmicrobio.2010.09.009.

Chen LL, Shi WP, Zhang TD, Zhou YQ, Zhao FZ, Ge WY, et al. Antibacterial activity of lysozyme-loaded cream against MRSA and promotion of scalded wound healing. Int J Pharm. 2022 Nov 5;627:122200. doi: 10.1016/j.ijpharm.2022.122200.

Sziegat F, Wirmer-Bartoschek J, Schwalbe H. Characteristics of human lysozyme and its disease-related mutants in their unfolded states. Angew Chem Int Ed Engl. 2011;50(24):5514–18; doi: 10.1002/anie.201008040.

Palmieri B, Boraldi F. [Topical treatment of some dystrophic and inflammatory lesions of the skin and soft tissues]. Arch Sci Med (Torino) 1977;134(4):481–5. Italian.

He W, Wang X, Hang T, Chen J, Wang Z, Mosselhy DA, et al. Fabrication of Cu2+-loaded phase-transited lysozyme nanofilm on bacterial cellulose: Antibacterial, anti-inflammatory, and pro-angiogenesis for bacteria-infected wound healing. Carbohydr Polym. 2023 Jun 1;309:120681. doi: 10.1016/j.carbpol.2023.120681.

Wang H, Huang R, Bai L, Cai Y, Lei M, Bao C, et al. Extracellular matrix-mimetic immunomodulatory hydrogel for accelerating wound healing. Adv Healthc Mater. 2023 Oct;12(27):e2301264. doi: 10.1002/adhm.202301264.

Gong W, He WY, Hou YY, Li YX, Hu JN. Tendon-inspired hybrid hydrogel based on polyvinyl alcohol and gallic acid-lysozyme for promoting wound closure and healing. Int J Biol Macromol. 2023 Aug 30;247:125583. doi: 10.1016/j.ijbiomac.2023.125583.

Meng X, Xiong H, Ji F, Gao X, Han L, Wu Z, et al. Facile surface treatment strategy to generate dense lysozyme layer on ultra-high molecular weight polyethylene enabling inhibition of bacterial biofilm formation. Colloids Surf B Biointerfaces. 2023 May;225:113243. doi: 10.1016/j.colsurfb.2023.113243.

Zhao M, Huang M, Li Z. Exploring the therapeutic potential of recombinant human lysozyme: a review on wound management system with antibacterial. Front Bioeng Biotechnol. 2023;11:1292149; doi: 10.3389/fbioe.2023.1292149.

Chen J, Xu M, Wang L, Li T, Li Z, Wang T, Li P. Converting lysozyme to hydrogel: A multifunctional wound dressing that is more than antibacterial. Colloids Surf B Biointerfaces. 2022 Nov;219:112854. doi: 10.1016/j.colsurfb.2022.112854.

Sugiyama N, Koyama H, Akamatsu J, et al. Treatment of skin ulcers with lysozyme chloride. Acta Dermatologica 1990;85(2):269–284.

Gasior-Chrzan B. [Clinical trial of lysozyme treatment of crural ulcers in humans]. Przegl Dermatol 1988;75(6):435–8. Polish.

The Japanese Societyof Pressure Ulcers Guideline Revision Committee; Noda Y, Sekine Y, Kaitani T, et al. JSPU Guidelines for the prevention and management of pressure ulcers (3rd edition). Jpn J PU. 2014;16(1):12–90.

Tahir Mahmood D, Kareem Qadir H, Mohammed Hussein M. Relationship between characteristics of the wound and healing duration among patients treated during home-visits. Arch Razi Inst. 2023;78(4):1323–32; doi: 10.32592/ARI.2023.78.4.1323.

Yoshikawa Y, Maeshige N, Tanaka M, Uemura M, Hiramatsu T, Fujino H, et al. Relationship between cleaning frequency and pressure ulcer healing time in older people receiving home care. J Wound Care. 2024 Jun 2;33(6):418-24. doi: 10.12968/jowc.2021.0152.

Kaya AZ, Turani N, Akyüz M. The effectiveness of a hydrogel dressing compared with standard management of pressure ulcers. J Wound Care 2005;14(1):42–4; doi: 10.12968/jowc.2005.14.1.26726.

Chen B, Liu Y, Liu Y, Xu S. Distribution characteristics of pathogens in different stages of pressure ulcers and the therapeutic effect of linear polarized polychromatic light combined with silver sulfadiazine cream. Medicine (Baltimore). 2023 Oct 20;102(42):e35772. doi: 10.1097/MD.0000000000035772.

Salton MR. The lysis of micro-organisms by lysozyme and related enzymes. J Gen Microbiol. 1958;18(2):481–90; doi: 10.1099/00221287-18-2-481.

Dožić I, Todorović T. Antimicrobial peptides of human saliva. Stomatoloski glasnik Srbije 2005;52(4):208–16.

Bioptron. n.d. How Bioptron Hyperlight Therapy System Works? [Internet] [Cited: 11-Oct-2024]. Available from: https://www.bioptron.com/how-it-works/bioptron-hyperlight-therapy/.

Published
2025/04/30
Section
Original article